We are live on ! Find out more
NCNMGF

Nano-Cap New Millennium Growth Fund Portfolio holdings

AUM $130M
This Fund
S&P 500
This Quarter Est. Return
+2.74%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$117M
AUM Growth
–
Cap. Flow
+$120M
Cap. Flow %
102.24%
Top 10 Hldgs %
23.19%
Holding
170
New
170
Increased
–
Reduced
–
Closed
–
Avg Time Held
0 quarters
Top 10 Avg Time Held
0 quarters
Top 20 Avg Time Held
0 quarters

Top Buys

Rank Stock Value
1
KWEB icon
KraneShares CSI China Internet ETF
KWEB
+$3.81M
2
U icon
Unity
U
+$3.42M
3
THRM icon
Gentherm
THRM
+$3.42M
4
SILC icon
Silicom
SILC
+$2.8M
5
PSNL icon
Personalis
PSNL
+$2.54M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 43.97%
2 Healthcare 23.99%
3 Miscellaneous 9.7%
4 Communication Services 9.18%
5 Consumer Discretionary 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
KZR
126
DELISTED
Kezar Life Sciences
KZR
$157K 0.13%
+25,000
New +$146K
2025 Q4
0 quarters
DJP icon
127
iPath Bloomberg Commodity Index Total Return ETN due 12 June 2036
DJP
$882M
$150K 0.13%
+4,000
New +$148K
2025 Q4
0 quarters
ACCS
128
ACCESS Newswire
ACCS
$17.6M
$140K 0.12%
+15,000
New +$137K
2025 Q4
0 quarters
PHVS icon
129
Pharvaris
PHVS
$2.18B
$139K 0.12%
+5,000
New +$120K
2025 Q4
0 quarters
BZUN
130
Baozun
BZUN
$189M
$133K 0.11%
+50,000
New +$157K
2025 Q4
0 quarters
MRNA icon
131
Moderna
MRNA
$78.6B
$133K 0.11%
+4,500
New +$122K
2025 Q4
0 quarters
BE icon
132
Bloom Energy
BE
$80.4B
$130K 0.11%
+1,500
New +$158K
2025 Q4
0 quarters
ORIC icon
133
Oric Pharmaceuticals
ORIC
$1.25B
$123K 0.1%
+15,000
New +$173K
2025 Q4
0 quarters
PASG icon
134
Passage Bio
PASG
$12.2M
$118K 0.1%
+10,000
New +$86.3K
2025 Q4
0 quarters
DV icon
135
DoubleVerify
DV
$2.11B
$114K 0.1%
+10,000
New +$110K
2025 Q4
0 quarters
NTLA icon
136
Intellia Therapeutics
NTLA
$1.77B
$112K 0.1%
+12,500
New +$172K
2025 Q4
0 quarters
BOLT icon
137
Bolt Biotherapeutics
BOLT
$7.03M
$112K 0.1%
+20,500
New +$110K
2025 Q4
0 quarters
OPRA
138
Opera Ltd
OPRA
$1.5B
$106K 0.09%
+7,500
New +$111K
2025 Q4
0 quarters
CGEM icon
139
Cullinan Oncology
CGEM
$995M
$104K 0.09%
+10,000
New +$90.2K
2025 Q4
0 quarters
LXFR icon
140
Luxfer Holdings
LXFR
$465M
$101K 0.09%
+7,500
New +$97.6K
2025 Q4
0 quarters
FIG
141
Figma
FIG
$12.1B
$93.4K 0.08%
+2,500
New +$113K
2025 Q4
0 quarters
HAP icon
142
VanEck Natural Resources ETF
HAP
$333M
$90.2K 0.08%
+1,500
New +$87.9K
2025 Q4
0 quarters
WPM icon
143
Wheaton Precious Metals
WPM
$61.3B
$88.1K 0.08%
+750
New +$80.3K
2025 Q4
0 quarters
BLLN
144
BillionToOne Inc
BLLN
$4.5B
$81.8K 0.07%
+1,000
New +$101K
2025 Q4
0 quarters
DOW icon
145
Dow Inc
DOW
$20.7B
$81.8K 0.07%
+3,500
New +$80.5K
2025 Q4
0 quarters
AA icon
146
Alcoa
AA
$11.3B
$79.7K 0.07%
+1,500
New +$61.4K
2025 Q4
0 quarters
NIKL icon
147
Sprott Nickel Miners ETF
NIKL
$48.2M
$78.7K 0.07%
+5,000
New +$72.6K
2025 Q4
0 quarters
RPID icon
148
Rapid Micro Biosystems
RPID
$43.2M
$72.5K 0.06%
+25,000
New +$86.8K
2025 Q4
0 quarters
AMBA icon
149
Ambarella
AMBA
$2.78B
$70.8K 0.06%
+1,000
New +$80.8K
2025 Q4
0 quarters
A icon
150
Agilent Technologies
A
$47.4B
$68K 0.06%
+500
New +$71.9K
2025 Q4
0 quarters

Similar funds

Nano-Cap New Millennium Growth Fund's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for Nano-Cap New Millennium Growth Fund, which disclosed 170 positions worth $117M. Its ten largest holdings account for 23% of the portfolio.

Its largest position is KraneShares CSI China Internet ETF: 99,000 shares worth $3.37M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, followed by Healthcare and Miscellaneous.

  • Nano-Cap New Millennium Growth Fund's largest Q4 2025 buy was KraneShares CSI China Internet ETF: 99,000 shares worth $3.37M.
  • Nano-Cap New Millennium Growth Fund's ten largest holdings make up 23% of its $117M portfolio in Q4 2025.
  • Nano-Cap New Millennium Growth Fund disclosed 170 positions in Q4 2025, its first 13F filing on record.

Based on Nano-Cap New Millennium Growth Fund's 13F filing for Q4 2025, filed 6 Feb 2026.